Walgreens has sold more shares of drug distributor Cencora for proceeds of about $300 million in the latest effort to pay ...

The sale netted about $300 million for Walgreens and shrinks the company’s stake in Cencora to approximately 6%, down from 10 ...

In yet another move to pay down debt that matures in 2026, Walgreens Boots Alliance announced last night it would receive ...

The company said that it now owns a 6% stake in Cencora, trimming it down from 10% it previously held. It sold Cencora shares ...

Walgreens Boots Alliance further reduced stake in Cencora. Walgreens reports early settlement of certain prepaid variable share forward transactions with respect to shares of Cencora for delivery of ...

Drug distributor Cencora (NYSE:COR) agreed to repurchase shares of its common stock from Walgreens Boots Alliance (NASDAQ:WBA) for ~$50M in concurrence with Walgreens Boots Alliance’s sale of Cencora ...

Walgreens Boots Alliance Inc. (WBA) said that it has reached an agreement to settle early on certain prepaid variable share forward ...

在最新的市场动态中，美国药品零售巨头沃尔格林联合博姿（Walgreens Boots ...

Cencora simplifies distribution logistics by shipping products to centralized wholesaler locations, as opposed to shipping directly to pharmacies and various customer locations. Additionally, Cencora ...

近日，美国连锁药店巨头沃尔格林联合博姿（Walgreens Boots Alliance）宣布出售其药品分销商Cencora的股份，套现约3亿美元。这一举动引发了投资者和市场的广泛关注与讨论。沃尔格林在Cencora的持股比例从10%降至6%，公司表示此次出售所得主要用于偿还债务和其他一般公司用途。这一消息不仅对沃尔格林的未来战略方向有重大影响，也对投资者的决策产生深远影响。 沃尔格林联合博姿是全 ...